NCT04929028 2026-04-13
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Sun Yat-sen University
Stanford University
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Peking University Cancer Hospital & Institute
Peking University Cancer Hospital & Institute
University of Washington
Massachusetts General Hospital
National University Hospital, Singapore